On June 29, the 8th China Healthcare Industry Development and Investment Annual Conference (HDI) and the China Private Medical Discipline Development and Cooperation Conference - Huashan Forum grandly opened at the Xi'an International Convention Center. This annual conference brought together top experts, scholars, research institutions, corporate leaders, and healthcare administrators from the medical and healthcare industry and interdisciplinary fields to discuss the future development of private medical care and the cutting-edge progress in discipline construction.
At this annual meeting, a grand ceremony was held for the handover of the annual rotating chairman of the National Private Medical Oncology Development Cooperation Network. Dean Niu Lizhi of Guangzhou Fuda Cancer Hospital and General Manager Huang Huaipeng of Hebei Ping An Health Group jointly took over as the new annual rotating chairmen of the National Private Medical Oncology Development Cooperation Network. Taking over the banner of the annual rotating chairman, they also assumed the heavy responsibility of continuing to move forward and contributing their efforts to the development of the healthcare industry.
Handover Ceremony
Following the opening ceremony, multiple sub-forums were held simultaneously, where wisdom shone and sparks of ideas collided. As the new annual rotating chairman of the National Private Medical Oncology Development Cooperation Network, Dean Niu Lizhi delivered a speech at the forum on high-quality development and service model innovation in oncology (specializing in gastrointestinal tumors).
Dean Niu first extended his warm congratulations on the successful holding of this forum and expressed sincere welcome and heartfelt thanks to the participating leaders and experts. As a cross-regional, co-created, co-constructed, co-consulted, and shared public welfare learning cooperation mechanism, the cooperation network has promoted the application and dissemination of advanced concepts and treatment models of modern medicine in its member units through a series of effective industry exchanges, academic forums, technical training, and other activities, gradually exploring high-quality, sustainable development methods and paths with the characteristics of the private medical industry. He hoped that the representatives present would learn and gain from the forum, achieving the goal of improving the level of tumor diagnosis and treatment, and laying a solid foundation for discipline cooperation to better benefit patients.
At the conference, Dean Niu gave a speech on "Minimally Invasive Interventional Treatment of Pancreatic Cancer," explaining the clinical application and advantages of techniques such as cryoablation, nanoknife ablation, and iodine particle implantation in the treatment of pancreatic cancer. Pancreatic cancer is characterized by hidden onset, rapid progression, and extremely poor prognosis, with incidence and mortality rates showing a significant upward trend in recent years. Due to its definite efficacy, minimal trauma, and mild side effects, minimally invasive interventional treatment has been applied and developed in various tumors, and has even been recommended as a first-line treatment option in guidelines, gradually becoming a new choice for pancreatic cancer patients.
The academic forum held this time exchanged and discussed the hot and difficult issues in the field of oncology, not only spreading the forefront progress of the discipline but also promoting the multidisciplinary integration of tumor diagnosis and treatment. Guangzhou Fuda Cancer Hospital will take this opportunity to continue deepening the construction of clinical specialty departments, continuously improving medical technology levels and service quality, and striving to provide patients with more high-quality and efficient medical services.